The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
Recommendation is based on pivotal data from the phase III POLARIX study
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
Subscribe To Our Newsletter & Stay Updated
